Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Effectiveness of the XEN45 Glaucoma Treatment System in Patients With Angle Closure Glaucoma

NCT03362931 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT03362931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03362931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Effectiveness of the XEN45 Glaucoma Treatment System in Patients With Angle Closure Glaucoma
Lead sponsor
Allergan
Phase
Phase 3
Overall status
Completed
Start date
July 19, 2018
Completion date
March 18, 2022
Enrollment
65 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

angle-closure, glaucoma